Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-09-084664
Filing Date
2009-04-22
Accepted
2009-04-22 16:58:32
Documents
3
Period of Report
2009-05-22
Effectiveness Date
2009-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 335292
2 GRAPHIC g22822g67p72.jpg GRAPHIC 11651
3 GRAPHIC g22822g88s00.jpg GRAPHIC 10161
  Complete submission text file 0001193125-09-084664.txt   367334
Mailing Address 5800 PARK OF COMMERCE BLVD NW STE 322 BOCA RATON FL 33487
Business Address 5800 PARK OF COMMERCE BLVD N W STE 322 BOCA RATON FL 33487 5619895800
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1225
Type: DEF 14A | Act: 34 | File No.: 000-04829 | Film No.: 09764324
SIC: 2836 Biological Products, (No Diagnostic Substances)